cinacalcet has been researched along with Angina, Unstable in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chertow, GM; Franchetti, Y; Liu, S; Long, J; Mahnken, JD; Nolin, TD; Prokopienko, AJ; Stedman, MR; Stubbs, JR; West, RE | 1 |
Abdalla, S; Chertow, GM; Montez-Rath, ME; Parfrey, PS | 1 |
Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER | 1 |
1 trial(s) available for cinacalcet and Angina, Unstable
Article | Year |
---|---|
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate | 2017 |
2 other study(ies) available for cinacalcet and Angina, Unstable
Article | Year |
---|---|
Trimethylamine
Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Female; Hospitalization; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Methylamines; Middle Aged; Mortality; Myocardial Infarction; Randomized Controlled Trials as Topic; Renal Dialysis; Stroke | 2019 |
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
Topics: Aged; Angina, Unstable; Calcimimetic Agents; Cause of Death; Cinacalcet; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |